Gelesis was co-founded in by PureTech Ventures and has raised over $16M in financing to date. Gelesis is developing a breakthrough treatment for obesity and other gastrointestinal disorders. Gelesis' team of Scientific Advisors includes some of the world's leading obesity and GI experts.